Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Clinical experience of a subcutaneously anchored sutureless system for securing central venous catheters.

Pittiruti M, Scoppettuolo G, Dolcetti L, Celentano D, Emoli A, Marche B, Musarò A.

Br J Nurs. 2019 Jan 24;28(2):S4-S14. doi: 10.12968/bjon.2019.28.2.S4.

PMID:
30673323
2.

Clinical use of Sherlock-3CG® for positioning peripherally inserted central catheters.

Pittiruti M, Scoppettuolo G, Dolcetti L, Emoli A.

J Vasc Access. 2019 Jul;20(4):356-361. doi: 10.1177/1129729818805957. Epub 2018 Oct 18.

PMID:
30334475
3.

Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.

Galleu A, Riffo-Vasquez Y, Trento C, Lomas C, Dolcetti L, Cheung TS, von Bonin M, Barbieri L, Halai K, Ward S, Weng L, Chakraverty R, Lombardi G, Watt FM, Orchard K, Marks DI, Apperley J, Bornhauser M, Walczak H, Bennett C, Dazzi F.

Sci Transl Med. 2017 Nov 15;9(416). pii: eaam7828. doi: 10.1126/scitranslmed.aam7828.

4.

Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery.

Trento C, Marigo I, Pievani A, Galleu A, Dolcetti L, Wang CY, Serafini M, Bronte V, Dazzi F.

Haematologica. 2017 May;102(5):818-825. doi: 10.3324/haematol.2016.155390. Epub 2017 Feb 9.

5.

Ultrasound-guided "short" midline catheters for difficult venous access in the emergency department: a retrospective analysis.

Scoppettuolo G, Pittiruti M, Pitoni S, Dolcetti L, Emoli A, Mitidieri A, Migliorini I, Annetta MG.

Int J Emerg Med. 2016 Dec;9(1):3. doi: 10.1186/s12245-016-0100-0. Epub 2016 Feb 4.

6.

Diffusion and transmission of carbapenem-resistant Klebsiella pneumoniae in the medical and surgical wards of a university hospital in Milan, Italy.

Ridolfo AL, Rimoldi SG, Pagani C, Marino AF, Piol A, Rimoldi M, Olivieri P, Galli M, Dolcetti L, Gismondo MR.

J Infect Public Health. 2016 Jan-Feb;9(1):24-33. doi: 10.1016/j.jiph.2015.05.008. Epub 2015 Jun 23.

7.

Further benefits of cyanoacrylate glue for central venous catheterisation.

Scoppettuolo G, Dolcetti L, Emoli A, La Greca A, Biasucci DG, Pittiruti M.

Anaesthesia. 2015 Jun;70(6):758. doi: 10.1111/anae.13105. No abstract available.

8.

Closed vs open systems: when should short peripheral intravenous catheters be the first choice?

Vallecoccia MS, De Pascale G, Taraschi C, De Angelis Durante R, Dolcetti L, Pittiruti M, Scoppettuolo G.

J Hosp Infect. 2015 Jan;89(1):72-3. doi: 10.1016/j.jhin.2014.09.010. Epub 2014 Oct 19. No abstract available.

PMID:
25458742
9.

Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvant.

Fernández A, Mesa C, Marigo I, Dolcetti L, Clavell M, Oliver L, Fernández LE, Bronte V.

J Immunol. 2011 Jan 1;186(1):264-74. doi: 10.4049/jimmunol.1001465. Epub 2010 Dec 6.

10.

Measurement of myeloid cell immune suppressive activity.

Dolcetti L, Peranzoni E, Bronte V.

Curr Protoc Immunol. 2010 Nov;Chapter 14:Unit 14.17. doi: 10.1002/0471142735.im1417s91.

PMID:
21053303
11.

Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, Dolcetti L, Ugel S, Sonda N, Bicciato S, Falisi E, Calabrese F, Basso G, Zanovello P, Cozzi E, Mandruzzato S, Bronte V.

Immunity. 2010 Jun 25;32(6):790-802. doi: 10.1016/j.immuni.2010.05.010. Epub 2010 Jun 3.

12.

Myeloid-derived suppressor cell heterogeneity and subset definition.

Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V.

Curr Opin Immunol. 2010 Apr;22(2):238-44. doi: 10.1016/j.coi.2010.01.021. Epub 2010 Feb 17. Review.

PMID:
20171075
13.

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

Dolcetti L, Peranzoni E, Ugel S, Marigo I, Fernandez Gomez A, Mesa C, Geilich M, Winkels G, Traggiai E, Casati A, Grassi F, Bronte V.

Eur J Immunol. 2010 Jan;40(1):22-35. doi: 10.1002/eji.200939903.

14.

Myeloid-derived suppressor cell role in tumor-related inflammation.

Dolcetti L, Marigo I, Mantelli B, Peranzoni E, Zanovello P, Bronte V.

Cancer Lett. 2008 Aug 28;267(2):216-25. doi: 10.1016/j.canlet.2008.03.012. Epub 2008 Apr 22. Review.

PMID:
18433992
15.

[Implementation of a safety and health planning system in a teaching hospital].

Mariani F, Bravi C, Dolcetti L, Moretto A, Palermo A, Ronchin M, Tonelli F, Carrer P.

G Ital Med Lav Ergon. 2007 Jul-Sep;29(3 Suppl):429-31. Italian.

PMID:
18409761
16.

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V.

Immunol Rev. 2008 Apr;222:162-79. doi: 10.1111/j.1600-065X.2008.00602.x. Review.

PMID:
18364001
17.

Role of arginine metabolism in immunity and immunopathology.

Peranzoni E, Marigo I, Dolcetti L, Ugel S, Sonda N, Taschin E, Mantelli B, Bronte V, Zanovello P.

Immunobiology. 2007;212(9-10):795-812. Epub 2007 Nov 14. Review.

PMID:
18086380
18.

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.

Serafini P, Meckel K, Kelso M, Noonan K, Califano J, Koch W, Dolcetti L, Bronte V, Borrello I.

J Exp Med. 2006 Nov 27;203(12):2691-702. Epub 2006 Nov 13.

19.

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

Gallina G, Dolcetti L, Serafini P, De Santo C, Marigo I, Colombo MP, Basso G, Brombacher F, Borrello I, Zanovello P, Bicciato S, Bronte V.

J Clin Invest. 2006 Oct;116(10):2777-90.

20.

Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention.

Bronte V, Cingarlini S, Marigo I, De Santo C, Gallina G, Dolcetti L, Ugel S, Peranzoni E, Mandruzzato S, Zanovello P.

Immunol Invest. 2006;35(3-4):327-57. Review.

PMID:
16916757
21.

An outbreak of Serratia marcescens bloodstream infections associated with misuse of drug vials in a surgical ward.

Pan A, Dolcetti L, Barosi C, Catenazzi P, Ceruti T, Ferrari L, Magri S, Quiros Roldan E, Soavi L, Carnevale G.

Infect Control Hosp Epidemiol. 2006 Jan;27(1):79-82. Epub 2006 Jan 6.

PMID:
16418994
22.

Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA.

Pan A, Carnevale G, Catenazzi P, Colombini P, Crema L, Dolcetti L, Ferrari L, Mondello P, Signorini L, Tinelli C, Quiros Roldan E, Carosi G.

Infect Control Hosp Epidemiol. 2005 Feb;26(2):127-33.

PMID:
15756881
23.

Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination.

De Santo C, Serafini P, Marigo I, Dolcetti L, Bolla M, Del Soldato P, Melani C, Guiducci C, Colombo MP, Iezzi M, Musiani P, Zanovello P, Bronte V.

Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4185-90. Epub 2005 Mar 7.

24.

Derangement of immune responses by myeloid suppressor cells.

Serafini P, De Santo C, Marigo I, Cingarlini S, Dolcetti L, Gallina G, Zanovello P, Bronte V.

Cancer Immunol Immunother. 2004 Feb;53(2):64-72. Epub 2003 Oct 30. Review.

PMID:
14593498
25.

Susceptibility to genetic damage and cell types in Mediterranean mussels.

Dolcetti L, Venier P.

Mar Environ Res. 2002 Sep-Dec;54(3-5):487-91.

PMID:
12408606
26.

DNA adducts in mussels and fish exposed to bulky genotoxic compounds.

Dolcetti L, Zuanna LD, Venier P.

Mar Environ Res. 2002 Sep-Dec;54(3-5):481-6.

PMID:
12408605
27.

[Evaluation of the efficacy of a program to control nosocomial spread of methicillin-resistant Staphylococcus aureus].

Pan A, Catenazzi P, Ferrari L, Tinelli C, Seminari E, Ratti A, Carnevale G, Cogrossi A, Crema L, Dolcetti L, Barosi C, Granata L, La Russa A, Poli N, Tomasoni D, Ceruti T.

Infez Med. 2001 Sep;9(3):163-9. Italian.

Supplemental Content

Loading ...
Support Center